Lake et al. HCA Healthcare Journal of Medicine (2021) 2:1
https://doi.org/10.36518/2689-0216.1125

Case Report
Esophageal Cancer Complicated by a Distal Acquired
Esophagopulmonary Fistula
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Esophageal respiratory fistulas, commonly found as a tracheoesophageal fistula (TEF),
are abnormal connections between the esophagus and trachea. These can be congenital
(infants) or acquired (malignancy). A more rare form of an esophageal respiratory fistula is
an abnormal connection between the esophagus and the lung parenchyma—also known as
an esophagopulmonary fistula. In our case, we present a middle-aged male with a history
of esophageal cancer undergoing chemotherapy and radiation presenting into the intensive
care unit for increasing shortness of breath and vomiting after eating found to have a rare
form of a TEF causing his symptoms.
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Introduction

Esophageal cancer is most commonly squamous cell carcinoma, comprising approximately
9 out of every 10 cases worldwide.1 Tobacco and
alcohol use are the two most common risk factors for esophageal squamous cell carcinoma
within the United States. Gastroesophageal
reflux disease (GERD) and Helicobacter pylori
are the two most common risk factors for the
development of esophageal adenocarcinoma.2
The overall peak age of onset is between 50
to 75 years old. Males typically are twice as
likely to develop esophageal cancer regardless
of the histologic subtype.3 Esophageal cancer
should be suspected in individuals presenting
with known risk factors—along with persistent
dyspepsia despite medically optimized treatment—progressive dysphagia—usually solids
first then liquids—and significant weight loss.
An esophagogastroduodenoscopy (EGD) is the
diagnostic test of choice with endoscopic biopsies making the diagnosis. The most common
complication of standard therapy for esophageal cancer (preoperative chemo radiation, surgery or perioperative chemotherapy depend-

ing on the disease stage) is dysphagia and an
esophageal obstruction.3 Another complication
of therapy is the development of an abnormal
connection between the esophagus and pulmonary system. An acquired tracheoesophageal
fistula is the most familiar subtype. However,
a more rare form is an esophagopulmonary
fistula—an abnormal connection between the
esophagus and the lung parenchyma. In our
case, a middle-aged male, with a history of
esophageal cancer undergoing chemotherapy
and radiation, presented into the intensive care
unit (ICU) for increasing shortness of breath
and vomiting after eating and drinking.

Case Presentation

We present a case of a 60-year-old male with a
past medical history of esophageal squamous
cell carcinoma status post-chemotherapy and
radiation. The patient used tobacco and alcohol
and was medically noncompliant. The patient
presented with a 3 to 4 day history of shortness of breath with productive cough as well as
nausea and vomiting after eating or drinking.
The symptoms worsened when lying flat. He
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Table 1. Emergency Department Laboratory Values.
Test
Patient’s Value

Reference Range

Hemoglobin

11.8 g/dl

12.0–18.0 g/dl

Serum leukocyte count

17.4 x 109/L - 88.5% Neutrophils

4.8–10.8 x 109/L

Platelets

363 x 109/L

125–400 x 103/mcL

Aspartate transaminase (AST)

96 U/L

15–37 U/L

Alanine transami-nase (ALT)

95 U/L

12–78 U/L

stated that when he consumed either food or
drink he began to cough persistently, which led
to emesis. These symptoms prompted the patient to seek help as he was unable to swallow
with worsening shortness of breath.
Pertinent history for his esophageal squamous
cell carcinoma shows he underwent a combination of chemotherapy (carboplatin-paclitaxel)
for 6 weeks and had 28 radiation visits from the
time of his diagnosis in July 2018 to when he
presented to the ICU. A recent positron emission tomography (PET) scan revealed localized disease in the esophagus with a decrease
in size of the malignant tumor compared to
the prior radiograph. He had been referred to
multiple thoracic surgeons and was offered
the option of surgical resection. Due to insurance issues, this resection was unfortunately
delayed, and the patient’s condition worsened,
leading to the current presentation.
The patient presented to our ICU around 2
months after his last visit with a thoracic surgeon. The patient’s initial vital signs included a
temperature of 38.6°F, heart rate of 122 beats
per minute, blood pressure of 162/84 mmHg

and 92% oxygen saturation on 2 liters nasal
cannula. Initial labs revealed a neutrophilic
leukocytosis, mild normocytic anemia and liver
transaminase elevation. (Table 1)
A chest x-ray revealed bilateral pulmonary
opacities, suspicion for pneumonia and the possibility of COVID-19. These results led to appropriate testing and isolation precautions. He was
started on empiric antibiotics with vancomycin,
metronidazole and cefepime. Oncology, gastroenterology and pulmonology consultations
were ordered by the primary care physician
with admission to the medical floor.
COVID-19 PCR testing was negative. A computed tomography (CT) angiogram was ordered and is shown in Figure 1. The findings
included a large right upper lobe airspace
opacity, consolidation with a large area of
necrosis, tissue fragmentation and a thick-wall
cavitary lesion with significant pleural thickening medially with fistula formation between
the esophagus and lung parenchyma. A barium
esophagram confirmed an esophagopulmonary
fistula. (Figure 2)

Figure 1. A CT Angiogram shows a large right upper lobe airspace opacity, consolidation with a
large area of necrosis, tissue fragmentation and a thick-wall cavitary lesion with significant pleural
thickening medially with fistula formation between the esophagus and lung parenchyma.
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Figure 2. A barium esophagram shows an esophagopulmonary fistula.
An esophagogastroduodenoscopy (EGD) with
possible stent placement was planned for the
following day. An EGD was completed revealing
moderate diffuse gastritis, a friable esophageal
tumor from 22–29 cm, and evidence of a 1 cm
esophagopulmonary fistula at 23 cm. Unfortunately, the patient went into respiratory
distress during the procedure and required an
abortion of the procedure prior to stent placement. The patient was then sent to the intensive care unit and required mechanical ventilation. After the pulmonary stabilization and
clearance, the patient underwent EGD with
the placement of a Boston Scientific WallFlex
fully coated esophageal stent. This procedure
was well tolerated without complications. A
pureed diet was initially tolerated following the
procedure with a slow advancement of diet and
improving respiratory complaints.

Discussion

This case illustrates a patient with prior localized esophageal squamous cell carcinoma who
developed a rare complication that lead to debilitating symptoms. The case was complicated
by medical noncompliance, and the concurrent
COVID-19 pandemic potentially affected an
immunocompromised host. Tracheoesophageal
fistulas (TEFs) occur in <15% of patients with
esophageal cancers, and, if untreated, they significantly increase morbidity and mortality (4).
Esophagopulmonary fistulas account for 3–11%

of TEFs and are considered the least common
subtype (5). The majority of TEFs are found
in the middle 1/3rd of the esophagus. Distal
esophageal fistulas are less common and are
more prone to an abnormal connection with
the major bronchi. Current standard therapy
is dependent on whether or not concurrent
airway stenosis is present, without which an
esophageal stent alone is sufficient. If there
is airway stenosis and esophagopulmonary
fistula, then double stenting with a bronchial and esophageal stent is indicted.5 Prompt
recognition of this rare type of TEF in patients
with malignancy can lead to early palliative
approaches and symptomatic relief.
Early recognition is of utmost importance for
clinicians diagnosing TEFs in patients with
esophageal cancer. A multidisciplinary strategy
involving gastroenterology, oncology, pulmonology and occasionally thoracic surgery is
essential to management. Without treatment,
mortality increases as do dire consequences,
including pulmonary abscess, pulmonary pseudoaneurysms and life-threatening hemoptysis.6
For patients deemed poor surgical candidates,
an endoscopic approach with stenting can be
a safe palliative alternative and can improve
quality of life. Future studies are needed to establish the guideline-driven treatment of adults
with acquired tracheo- and broncho-esophageal fistulas.

49

HCA Healthcare Journal of Medicine

Acknowledgements

The patient provided informed consent.

Conflicts of Interest

The authors declare they have no conflicts of
interest.
The authors are employees of Regional Medical
Center Bayonet Point, a hospital affiliated with
the journal’s publisher.
This research was supported (in whole or in
part) by HCA Healthcare and/or an
HCA Healthcare affiliated entity. The views
expressed in this publication represent those of
the author(s) and do not necessarily represent
the official views of HCA Healthcare or any of
its affiliated entities.
1.

Author Affiliations

Regional Medical Center Bayonet Point,
Hudson, FL

References
1.

2.

3.

4.

5.

6.

50

Freedman ND, Abnet CC, Leitzmann MF, et al.
A prospective study of tobacco, alcohol, and the
risk of esophageal and gastric cancer subtypes.
Am J Epidemiol. 2007;165(12):1424-1433. https://
doi.org/10.1093/aje/kwm051
Bray F, Ferlay J, Soerjomataram I, Siegel RL,
Torre LA, Jemal A. Global cancer statistics 2018:
GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018;68(6):394-424. https://doi.
org/10.3322/caac.21492
National Comprehensive Cancer Network.
Esophageal and Esophagogastric Junction
Cancers (Version 3.2015). https://www.nccn.org/
professionals/physician_gls/pdf/esophageal.pdf
Ke M, Wu X, Zeng J. The treatment strategy for tracheoesophageal fistula. J Thorac
Dis. 2015;7(Suppl 4):S389-S397. https://doi.
org/10.3978/j.issn.2072-1439.2015.12.11
Duranceau A, Jamieson GG. Malignant tracheoesophageal fistula. Ann Thorac Surg.
1984;37(4):346-354. https://doi.org/10.1016/
s0003-4975(10)60745-x
Rehders A, Baseras B, Telan L, et al. Esophageal
cancer complicated by esophagopulmonary
fistula and lung abscess formation: A surgical
approach. Thorac Cancer. 2014;5(5):468-471.
https://doi.org/10.1111/1759-7714.12118

